Publication | Open Access
RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
312
Citations
19
References
2015
Year
The combination of siG12D-LODER™ and chemotherapy is well tolerated, safe and demonstrated a potential efficacy in patients with LAPC. NCT01188785.
| Year | Citations | |
|---|---|---|
Page 1
Page 1